1 / 4

Ketorolac Market 2020-2027: Market to Remain the Fastest Growing Market

Ketorolac is a non -steroidal anti-inflammatory drug (NSAIDu2019S) recommended for treatment of moderate or severe pain. Ketorolac is administrated by oral, parental and topical route of administration in human body.

5186
Download Presentation

Ketorolac Market 2020-2027: Market to Remain the Fastest Growing Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Ketorolac Market 2020-2027: Market to Remain the Ketorolac Market 2020-2027: Market to Remain the Fastest Growing Market Fastest Growing Market Ketorolac is a non -steroidal anti-inflammatory drug (NSAID’S) recommended for treatment of moderate or severe pain. Ketorolac is administrated by oral, parental and topical route of administration in human body. Ketorolac is used for short duration treatment, physicians recommend ketorolac for less than 6 days of treatment. Moreover, ketorolac functions as inhibitor of prostaglandin synthesis, having anti-inflammatory, antipyretic and analgesic properties and helps in lowering the contraction/relaxation of smooth muscles in the human body. Request Sample Report: Request Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/4170 https://www.coherentmarketinsights.com/insight/request-sample/4170 Global Ketorolac Market Drivers Global Ketorolac Market Drivers Ketorolac has diversified medicinal use such as, ketorolac with paracetamol controls pain without affecting respiration in infants, used in treatment of dysmenorrhea, used as eye drop during eye surgery to surge pain in patients. Thus, due to diversified used in different medical conditions, pharmaceutical companies are focusing on research and development to strengthen their market share in global ketorolac market. For instance, in 2017, Cycle Pharmaceutical announced the approval of 30mg/ml ketorolac tromethamine injection by United States Food Drug and Administration as Abbreviated New Drug Application in United States. Global Ketorolac Market COVID-19 Impact Analysis Global Ketorolac Market COVID-19 Impact Analysis The COVID-19 pandemic has impacted growth of various markets and it is also expected to hamper the growth of global ketorolac market during the forecast period. Moreover, safety precaution suggested by World Health Organization to reduce the risk of spread of COVID-19 and implementation of nationwide lockdowns has affected the supply chain of ketorolac to pharmaceutical companies and higher shipping prices due to reduced excipient supply containers.

  2. Global Ketorolac Market Restraints Global Ketorolac Market Restraints The dosing frequency of ketorolac is only for 5 days in human beings, if dose of ketorolac exceeds more than 5 days leads to severe side effects such as gastro intestinal bleeding, ulcers and coagulation disorders. Therefore, use of ketorolac as a short duration treatment in moderate pain is expected to restrain the global ketorolac market. Global Ketorolac Market Regional Analysis Global Ketorolac Market Regional Analysis On the basis of region global ketorolac market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to witness significant growth in global ketorolac market owing to pharmaceutical companies focusing on Product launches in non-steroidal anti-inflammatory drugs for management of severe and moderate pain. For instance, In 2018, Nephron pharmaceuticals Corporation, launched a novel opoid free analgesic drug BKK with drug content Bupivacaine, ketorolac and ketamine. In Europe, pharmaceutical companies are focusing on product approval in region to strengthen their market share in global ketorolac market. For instance, in 2018 Omerous Corporation announced approval for sales of phenylephrine and ketorolac solution (OMIDRA) as an intraocular solution by European Medical Agency. Global Ketorolac Market Key Players Global Ketorolac Market Key Players Key players operating in the global ketorolac market include Allergan plc, Deepcare Health Pvt Ltd, Cadila Healthcare Limited, Intas Pharmaceuticals Limited, Ranbaxy Laboratories Limited, Omeros Corporation, Nephron Pharmaceuticals Corporation, Cycle Pharmaceuticals Ltd, and Neon Laboratories Limited. Report includes chapters which deeply display the following deliverable about industry : Report includes chapters which deeply display the following deliverable about industry : • Ketorolac Market Research Objective and Assumption • Ketorolac Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Ketorolac Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Ketorolac Market, By Regions • Ketorolac Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.

  3. • Ketorolac Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Ketorolac Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Ketorolac Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion LIMITED TIME OFFER - Hurry Up! LIMITED TIME OFFER - Hurry Up! Get Discount For Buyers UPTO 30% OFF On Any Research Report Get Discount For Buyers UPTO 30% OFF On Any Research Report Apply Promo Code "CMIFIRST1000" And Get Instant Discount Of USD 1000 Apply Promo Code "CMIFIRST1000" And Get Instant Discount Of USD 1000 To Get Instant Access, Purchase Report Here @ To Get Instant Access, Purchase Report Here @ https://www.coherentmarketinsights.com/insight/ buy-now/4170 buy-now/4170 https://www.coherentmarketinsights.com/insight/ Market Taxonomy: Market Taxonomy: On the basis of indication, the global ketorolac market is segmented into: On the basis of indication, the global ketorolac market is segmented into: • Fever • Inflammation • Surgery Pain. • Dysmenorrhea • Others On the basis of formulation, the global ketorolac market is segmented into: On the basis of formulation, the global ketorolac market is segmented into: • Oral

  4. • Parental • Topical On the basis of region, the global ketorolac market is segmented into: On the basis of region, the global ketorolac market is segmented into: • North America • Latin America • Europe • Asia Pacific • Middle East • Africa About Coherent Market Insights About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action- ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Phone: US +12067016702 / UK +4402081334027 Email: Email: sales@coherentmarketinsights.com sales@coherentmarketinsights.com

More Related